doi:10.16150/j.1671-2870.2019.02.023

Abstract

CLC Number:

R541.4

Figures/Tables 1

References 43

[1]	Bayoumi AS, Aonuma T, Teoh JP, et al. Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases[J]. Acta Pharmacol Sin, 2018, 39(7):1100-1109.
[2]	Brown JM, Hazen SL. Microbial modulation of cardiovascular disease[J]. Nat Rev Microbiol, 2018, 16(3):171-181.
[3]	Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association[J]. Circulation, 2015, 131(4):e29-e322.
[4]	Kertai MD, Li YJ, Li YW, et al. Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery[J]. BMJ Open, 2015, 5(5):e006920.
[5]	Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants[J]. Nat Genet, 2009, 41(3):334-341.
[6]	CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, et al. Large-scale association analysis identifies new risk loci for coronary artery disease[J]. Nat Genet, 2013, 45(1):25-33.
[7]	Aron-Wisnewsky J, Clément K. The gut microbiome, diet, and links to cardiometabolic and chronic disorders[J]. Nat Rev Nephrol, 2016, 12(3):169-181.
[8]	Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. Proc Natl Acad Sci U S A, 2004, 101(44):15718-15723.
[9]	Kasselman LJ, Vernice NA, DeLeon J, et al. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity[J]. Atherosclerosis, 2018, 271:203-213.
[10]	Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis[J]. Nat Med, 2013, 19(5):576-585.
[11]	Trenteseaux C, Gaston AT, Aguesse A, et al. Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids[J]. Arterioscler Thromb Vasc Biol, 2017, 37(11):2053-2063.
[12]	Zeisel SH, Warrier M. Trimethylamine N-Oxide the Microbiome, and Heart and Kidney Disease[J]. Annu Rev Nutr, 2017, 37:157-181.
[13]	Bennett BJ, de Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regu-lation[J]. Cell Metab, 2013, 17(1):49-60.
[14]	Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic disea-ses[J]. Annu Rev Med, 2015, 66:343-359.
[15]	Fennema D, Phillips IR, Shephard EA. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease[J]. Drug Metab Dispos, 2016, 44(11):1839-1850.
[16]	Yancey PH, Rhea MD, Kemp KM, et al. Trimethylamine oxide, betaine and other osmolytes in deep-sea animals: depth trends and effects on enzymes under hydrostatic pressure[J]. Cell Mol Biol (Noisy-le-grand), 2004, 50(4):371-376.
[17]	Organ CL, Otsuka H, Bhushan S, et al. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Fai-lure[J]. Circ Heart Fail, 2016, 9(1):e002314.
[18]	Sheard NF, Zeisel SH. An in vitro study of choline uptake by intestine from neonatal and adult rats[J]. Pediatr Res, 1986, 20(8):768-772.
[19]	Koeth RA, Levison BS, Culley MK, et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO[J]. Cell Metab, 2014, 20(5):799-812.
[20]	Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature, 2011, 472(7341):57-63.
[21]	Hernandez D, Janmohamed A, Chandan P, et al. Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters[J]. Pharmacogenetics, 2004, 14(2):117-130.
[22]	Krueger SK, Williams DE. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism[J]. Pharmacol Ther, 2005, 106(3):357-387.
[23]	Ferreira F, Esteves S, Almeida LS, et al. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients[J]. Gene, 2013, 527(1):366-370.
[24]	Gao C, Catucci G, Castrignanò S, et al. Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine[J]. Sci Rep, 2017, 7(1):14668.
[25]	Ufnal M, Zadlo A, Ostaszewski R. TMAO: A small molecule of great expectations[J]. Nutrition, 2015, 31(11-12):1317-1323.
[26]	Cho CE, Caudill MA. Trimethylamine-N-Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?[J]. Trends Endocrinol Metab, 2017, 28(2):121-130.
[27]	Zhang AQ, Mitchell SC, Smith RL. Dietary precursors of trimethylamine in man: a pilot study[J]. Food Chem Toxicol, 1999, 37(5):515-520.
[28]	Zheng Y, Li Y, Rimm EB, et al. Dietary phosphatidylcholine and risk of all-cause and cardiovascular-specific mortality among US women and men[J]. Am J Clin Nutr, 2016, 104(1):173-180.
[29]	Ufnal M, Jazwiec R, Dadlez M, et al. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats[J]. Can J Cardiol, 2014, 30(12):1700-1705.
[30]	Liu M, Han Q, Yang J. Trimethylamine-N-oxide (TMAO) increased aquaporin-2 expression in spontaneously hypertensive rats[J/OL]. Clin Exp Hypertens, 2018-07-09[2018-07-03]https://www.ncbi.nlm.nih.gov/pubmed/29985655.
[31]	Tang WH, Wang Z, Shrestha K, et al. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure[J]. J Card Fail, 2015, 21(2):91-96.
[32]	Trøseid M, Ueland T, Hov JR, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure[J]. J Intern Med, 2015, 277(6):717-726.
[33]	Schugar RC, Brown JM. Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis[J]. Curr Opin Lipidol, 2015, 26(5):426-431.
[34]	Stender S, Frikke-Schmidt R, Nordestgaard BG, et al. The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease[J]. J Am Coll Cardiol, 2014, 63(20):2121-2128.
[35]	Warrier M, Shih DM, Burrows AC, et al. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance[J/OL]. Cell Rep, 2015-01-14[2018-07-03].https://www.ncbi.nlm.nih.gov/pubmed/25600868.
[36]	Febbraio M, Podrez EA, Smith JD, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice[J]. J Clin Invest, 2000, 105(8):1049-1056.
[37]	Suzuki H, Kurihara Y, Takeya M, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection[J]. Nature, 1997, 386(6622):292-296.
[38]	Makrecka-Kuka M, Volska K, Antone U, et al. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria[J]. Toxicol Lett, 2017, 267:32-38.
[39]	Shimizu M, Cashman JR, Yamazaki H. Transient trimethylaminuria related to menstruation[J]. BMC Med Genet, 2007, 8:2.
[40]	Gao X, Liu X, Xu J, et al. Dietary trimethylamine N-oxi-de exacerbates impaired glucose tolerance in mice fed a high fat diet[J]. J Biosci Bioeng, 2014, 118(4):476-481.
[41]	Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment[J]. Science, 2013, 342(6161):967-970.
[42]	Lever M, George PM, Slow S, et al. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study[J]. PLoS One, 2014, 9(12):e114969.
[43]	Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease[J]. Circ Res, 2015, 116(3):448-455.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 43

Related Articles 10

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(04): 349-355.
[2]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(03): 239-244.
[3]	SHENG Hong, ZHANG Andi. Study on application of nutritional risk screening in hospitalized patients with chronic heart failure [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 178-183.
[4]	WU Jie, FENG Yuanyuan, REN Yan, CAO Jiumei. Survey of risk factors of coronary heart disease in elderly patients with coronary angiography and establishment of relevant diagnostic model [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 201-206.
[5]	ZHA Qing, YU Chenxi, LIU Ya, YANG Ling, YE Jiawen, LIU Yan. Preliminary study on the role of miR-16 in progression of coronary atherosclerosis and possible molecular mechanism [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(01): 82-87.
[6]	LIU Shengjun, LIU Lili, ZHU Zhengbin, SUN Yi, ZHU Tianqi, FENG Shuo, CHEN Xin, QUAN Weiwei, ZHANG Ruiyan. Correlation of estimated glomerular filtration rate with incidence of in-stent restenosis in patients with drug-elu-ting stent [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 297-302.
[7]	LIU Shanshan, Niu Jingya, WANG Tiange, LI Mian, ZHAO Zhiyun, XU Yu, LU Jieli, XU Min, BI Yufang, ZHANG Di. Epidemiological investigation on cardiometabolic abnormalities in Songnan Community residents with type 2 diabetes [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 323-328.
[8]	HUANG Xiaoyi, CAI Wei, SHU Shizhen, PANG Xiaofen. Correlation of glycosylated hemoglobin and fasting blood glucose level with severity of lesion in elderly patients with carotid artery atherosclerosis [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 82-85.
[9]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 664-667.
[10]	LING Yuan, WANG Shuhong, LIANG Wei, SHEN Linhui. Study on correlation of serum level of C1q tumor necrosis factor-related protein 1（CTRP1) with coronary atherosclerotic heart disease [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(02): 199-203.